Recruiting NA Diabetes Mellitus

New treatment option for Diabetes Mellitus

Official title Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility

ClinicalTrials.gov ID: NCT05407207

What this study is testing

What it's testing
A high prevalence of diabetes has been reported in Qatar with nearly 23% population suffering from the pandemic, thereby increasing the associated healthcare cost. Low compliance with exercise and physical activity in patients with diabetes increases foot risk complications, deteriorates health, and further increases economic costs.
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 40 and older

You may be able to join if

  • Male and female patients with diabetes receiving dialysis who are \>40 years old.
  • Ambulatory (able to independently walk 20m with or without walking assistance).
  • Willing and able to provide informed consent.
  • Diabetes will be defined based on the American Diabetes Association (ADA) criteria (83).
  • Evidence of peripheral neuropathy and its severity will be determined based on a neurologic examination using criteria explained in the ADA statement.

You likely can't join if

  • Have an active foot ulcer, an active infection, Charcot neuroarthropathy, or major foot amputation.
  • Patients with any clinically significant medical or psychiatric condition, or laboratory abnormality that would, in the judgment of the...
  • Patients concurrently participating in exercise training; major hearing/visual impairment; any patient with changes in psychotropic or sleep...
  • If they were unlikely to fully comply with the follow-up protocol (e.g., travel plans).

The study team makes the final eligibility decision.

Where it's taking place

  • Houston, Texas, United States
  • Doha, Qatar

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Houston, Texas, United States; Doha, Qatar. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.